Falnidamol

• Description :

  Falnidamol (BIBX 1382) is an orally active, selective EGFR tyrosine kinase inhibitor with an IC50 of 3 nM. It displays >1000-fold lower potency against ErbB2 (IC50=3.4 μM) and other related tyrosine kinases (IC50>10 μM) . Falnidamol is a pyrimido-pyrimidine compound and exhibits anti-cancer activity.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  387.84

• Molecular Formula :

  C18H19ClFN7

• Notes :

  Research use only, not for human use.

• Receptor :

  EGFR

• CAS Number :

  196612-93-8